Kamyabi, Nabiollah
Abbasgholizadeh, Reza
Maitra, Anirban
Ardekani, Arezoo
Biswal, Sibani L.
Grande-Allen, K. Jane
Funding for this research was provided by:
National Cancer Institute (P30CA016672)
Cancer Prevention and Research Institute of Texas (RP170067)
Article History
First Online: 11 March 2020
Compliance with ethical standards
:
: A.M. discloses receiving royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for being a co-inventor on a license related to pancreatic cancer early detection, and this financial relationship is managed by the MD Anderson Conflict of Interest Committee. There are no other conflicts of interests to declare.